Seeking Alpha analyst Terry Chrisomalis regards Viking Therapeutics as the most attractive M&A candidate in 2025, bolstered by its strong obesity candidate VK2735 and largely de-risked MASH therapy VK2809. January 6, 2025· 2 min read· Tristan Manalac Regulatory 5 Companies That Celebrated Fir...